Donna Ludwinski
London Cancer(GB)Solving Kids' Cancer(US)
Publications by Year
Research Areas
Childhood Cancer Survivors' Quality of Life, CAR-T cell therapy research, Neuroblastoma Research and Treatments, Ethics in Clinical Research, Cancer therapeutics and mechanisms
Most-Cited Works
- → Paediatric Strategy Forum for medicinal product development of chimeric antigen receptor T-cells in children and adolescents with cancer(2021)37 cited
- → Pediatric cancer research: Surviving COVID‐19(2020)31 cited
- → Bromodomain and extra-terminal inhibitors—A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children—ACCELERATE(2021)30 cited
- → Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children(2020)25 cited
- → Paediatric Strategy Forum for medicinal product development of multi-targeted kinase inhibitors in bone sarcomas(2022)23 cited
- → The Critical Role of Academic Clinical Trials in Pediatric Cancer Drug Approvals: Design, Conduct, and Fit for Purpose Data for Positive Regulatory Decisions(2022)18 cited
- → To transplant, or not to transplant? That is the question. A patient advocate evaluation of autologous stem cell transplant in neuroblastoma(2022)15 cited
- → Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration(2023)14 cited
- → Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer(2024)9 cited
- → Paediatric strategy forum for medicinal product development in diffuse midline gliomas in children and adolescents ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration(2025)6 cited